Naomi Eichenbaum | executive |
Eric Dube | executive |
Jula Inrig | executive |
Peter Heerma | executive |
Chris Cline | executive |
Analyst | analyst |
Anupam Rama | analyst |
Maurice Raycroft | analyst |
Greg Harrison | analyst |
Vamil Divan | analyst |
Liisa Bayko | analyst |
Edwin Delfin | analyst |
William Rote | executive |
Laura Chico | analyst |
Alexander Thompson | analyst |
Allison Bratzel | analyst |
Antonio Arce | analyst |
Good day, and welcome to the Travere Therapeutics Third Quarter 2023 Financial Results and Corporate Update Conference Call. Today's conference call is being recorded. At this time, I'd like to turn the conference over to the Vice President of Investor Relations, Naomi Eichenbaum. Please go ahead, Naomi.
Thank you.